Related Experiment Video
Updated: Jul 21, 2026
08:39
Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
Published on: November 7, 2020
Risk factors for hyperlipidemia in long-term pediatric renal transplant recipients
D M Silverstein1, J Palmer, M S Polinsky
1Louisiana State University Medical Center, Department of Pediatrics, Division of Nephrology, 1542 Tulane Avenue, New Orleans, LA 70112, USA. DSilverst@aol.com
Pediatric Nephrology (Berlin, Germany)
|February 23, 2000
Summary
Hyperlipidemia is common in pediatric kidney transplant recipients, affecting over half of patients. Pre-existing hyperlipidemia and time since transplant are key risk factors for high cholesterol.
Area of Science:
- Nephrology
- Pediatric Transplantation
- Cardiovascular Health
Background:
- Hyperlipidemia (HL) is a significant concern in adult renal transplant (TP) recipients, increasing risks for cardiovascular disease and chronic transplant nephropathy.
- Multiple factors contribute to HL post-renal TP in adults, including pre-existing HL, immunosuppressants, renal dysfunction, hypoalbuminemia, obesity, and end-stage renal disease (ESRD).
Purpose of the Study:
- To evaluate the incidence and identify risk factors of hyperlipidemia (HL) in pediatric renal transplant recipients.
- To assess the prevalence of elevated serum cholesterol (C) and triglyceride (TG) levels in this population.
Main Methods:
- A study was conducted on 62 pediatric renal transplant recipients with functioning allografts.
- Data collected included serum cholesterol, triglyceride, LDL, and HDL levels, alongside clinical factors like pre-transplant HL, years since transplant, and GFR.
Main Results:
- Over half of the pediatric patients (51.6%) exhibited elevated serum cholesterol and triglyceride levels.
- Key risk factors for elevated cholesterol included pre-transplant HL and increased years post-transplant. Reduced GFR was linked to elevated triglycerides.
- Family history of HL significantly impacted serum C levels but not TG levels.
Conclusions:
- Post-renal transplant hyperlipidemia is a significant clinical issue in pediatric renal transplant recipients.
- Identifying and managing risk factors like pre-transplant HL and monitoring GFR are crucial for long-term graft and patient health.
Related Concept Videos
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
01:16Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
01:24Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...